Author:
Regani Harika,G. Honavar Santosh
Abstract
Ocular melanoma is the most common malignant tumor in adults after cutaneous melanoma. There is a wide clinical spectrum depending upon the location of the tumor. The various predispositions, risk factors, tumor classification, and treatment modalities are discussed. Choroidal melanoma is the most common type of ocular melanoma. Its management has evolved over the years. The Collaborative Ocular Melanoma Study (COMS) has helped to precisely classify choroidal melanoma and standardize its treatment. The future lies in the genetics which can help prognosticate and provide adjuvant treatment to patients at risk.
Reference34 articles.
1. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. 2013 [Cited: April 6, 2017]. Available from: http://globocan.iarc.fr. [Accessed: 26 July 2020]
2. McLaughlin CC, Wu XC, Jemal A, Martin HJ, Ro-Che LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005;103:1000-1007
3. Paul TF. Malignant Melanoma of the Eyelid. New York: Eye Cancer Centre; Available from: Eyecancer.com
4. Shields CL, Shields JA, Gunduz K, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol. 2000;118(11):1497-1507
5. Stremnel I, Kroll P. Conjunctival malignant melanoma in children. Journal of Ophthalmology. 1999;213:129-132